ISD-Immunotech
Biotechnology Research
Dk
1 employees
- Employees
- 1
ISD-Immunotech Overview
- Headquarters
- Dk
- Website
- isd-immunotech.com
- Industry
- Biotechnology Research
- Employees
- 1
- Founded
- 2013
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ISD-Immunotech
ISD Immunotech is developing STING modulators to treat severe Systemic lupus erythematosus (SLE) or Lupus by targeting the STING pathway. SLE is a complex and devastating autoimmune disease with few to no good options for treatment especially for the most severe patients. STimulator of INterferon Gene (STING) is a target that controls innate immunity and has shown to be overactive in severe SLE making it an exciting new therapeutic target for SLE.
ISD-Immunotech Contact Details
Compare Similar Companies to ISD-Immunotech
BiOrigin
Biotechnology Research
Galecto, Inc.
Biotechnology Research
Viking Invest
Residential Building Construction
HealthTunes.org
Hospitals And Health Care
Biomatics Technology
Biotechnology Research
Amino Wool
Biotechnology Research
CoboSci - Biomedical Research
Biotechnology Research
PanCryos
Biotechnology Research
Sylph
Biotechnology Research
SynapseBio
Software Development